Skip links

GSS EU Science Funding Gateway

Action grants to organise and collect data to understand the safety, quality and efficacy of therapies applied in the field of assisted reproduction and based on haematopoietic stem cells

Summary

The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:

  • protecting people from serious cross-border health threats
  • improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
  • strengthening national health systems

Programme Name

EU4Health Programme 2021-2027

Programme Description

The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:

  • protecting people from serious cross-border health threats
  • improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
  • strengthening national health systems
Programme Details

Call

Action grants to organise and collect data to understand the safety, quality and efficacy of therapies applied in the field of assisted reproduction and based on haematopoietic stem cells

Detailed Call Description

Hematopoietic stem cells play a significant role in the area of cancer immunotherapy, in particular in the treatment of liquid blood cancers like leukaemia and lymphoma.

The action supports the policy priority to respond to the COVID-19 crisis and implements the EU4Health Programme’s general objective of improving the availability, accessibility and affordability of medicinal products and medical devices, and crisis-relevant products in the Union, and of supporting innovation. This action will support Union data collection, aggregation and analysis on the use and outcome of therapies in the fields of:

  • assisted reproduction;
  • haematopoietic stem cells.
  • For both (a) and (b) it will facilitate the design, development and management of dedicated IT solutions with and for medical/healthcare professionals.

    Financing percentage by EU or other bodies / Level of Subsidy or Loan

    60% Applicants can apply for a higher project funding rate (maximum 80%) if your project is of ‘exceptional utility’.

    Eligibility For Participation Notes

    In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must:

    • be legal entities (public or private bodies) created under Union law or an international organisation, or
    • be established in one of the eligible countries, i.e.:
      • EU Member States (including overseas countries and territories linked to it (OCTs)
      • eligible non-EU countries: EEA countries and countries associated to the EU4Health Programme (third countries, candidate countries and potential candidate countries, neighbourhood countries) or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature.
    Programme Category
    EU Competitive Programmes
    Total Budget
    €4,000,000
    Thematic Categories
    • Health
    Eligibility for Participation
    • Central Government
    • International Organisations
    • NGOs
    • Non Profit Organisations
    • Private Bodies
    • State-owned Enterprises
    Call Opening Date
    14/10/2021
    Call Closing Date
    25/01/2022
    National Contact Point(s)

    Ministry of Health, Department of European Affairs

    Ms MAKRIGIORGI Elena
    emakrigiorgi@moh.gov.cy

    (Publish Date: 29/10/2021-for internal use only)

    EU Contact Point

    Stefan DE KEERSMAECKER
    Telephone: +32 2 298 46 80
    Email: stefan.de-keersmaecker@ec.europa.eu

    Darragh CASSIDY

    Telephone: +32 2 298 39 78
    Email: darragh.cassidy@ec.europa.eu

    Website
    Funding&Tenders Call document
    This website uses cookies to improve your web experience.
    Home
    Account
    Cart
    Search
    Explore
    Drag